Literature DB >> 4363357

Inhibition of 3',5'-cyclic AMP phosphodiesterase with anti-inflammatory agents.

V Stefanovich.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4363357

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


× No keyword cloud information.
  7 in total

1.  Cyclic adenosine 3', 5'-monophosphate and the mechanism of action of three common anti-inflammatory drugs.

Authors:  D A Deporter; C J Dunn; D A Willoughby
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

2.  Sensitivity to cyclic nucleotides and to aspirin of the kininogen-consuming system activated by adrenaline or carbamylcholine in rat blood.

Authors:  A M Rothschild; A Castania
Journal:  Agents Actions       Date:  1978-01

3.  Cyclic nucleotide phosphodiesterase inhibition by a benzoic acid derivative.

Authors:  J J Killackey; B A Killackey; R B Philp
Journal:  Agents Actions       Date:  1985-12

4.  The effect of inhibition of prostaglandin synthesis on tubuloglomerular feedback in the rat kidney.

Authors:  J Schnermann; G Schubert; M Hermle; R Herbst; N T Stowe; S Yarimizu; P C Weber
Journal:  Pflugers Arch       Date:  1979-04-30       Impact factor: 3.657

5.  Characteristics of histamine tachyphylaxis in canine tracheal smooth muscle.

Authors:  W H Anderson; J J Krzanowski; J B Polson; A Szentivanyi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

6.  Modes of action of aspirin-like drugs.

Authors:  S Abramson; H Korchak; R Ludewig; H Edelson; K Haines; R I Levin; R Herman; L Rider; S Kimmel; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

7.  Release of mediators of anaphylaxis: inhibition of prostaglandin synthesis and the modification of release of slow reacting substance of anaphylaxis and histamine.

Authors:  D M Engineer; U Niederhauser; P J Piper; P Sirois
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.